文献速递肺结节与肺癌

SUMMIT研究:肺癌筛查人群症状普遍且与肺癌风险相关

Symptom Prevalence and Impact on Lung Cancer Risk in the SUMMIT Study
RSS 订阅 · PubMed 顶刊 · 肺结节与肺癌筛查 · 2026-06-30

SUMMIT前瞻性观察队列研究纳入13035例符合基线低剂量CT筛查条件的参与者,评估自报呼吸道症状与警示症状的分布及其对筛查结局的影响。

要点

  • 筛查人群中76%至少报告1种症状,仅6%报告警示症状。
  • 咳嗽占36%、呼吸困难占66%,警示症状包括咯血与体重下降。
  • 存在任一症状与1年内肺癌诊断风险升高相关(OR 1.45)。

核心结论

  • 肺癌筛查参与者中症状报告常见,有症状者1年内肺癌诊断可能性更高。

研究设计与样本

  • SUMMIT为前瞻性观察队列研究,评估低剂量CT肺癌筛查实施情况。
  • 基线临床评估收集自报症状、病史、人口学资料与肺功能。
  • 共13035例符合基线低剂量CT筛查的参与者纳入分析。
  • 采用多变量logistic回归评估症状与肺癌的关联。

主要发现

  • 76%(n=9859)的参与者报告至少1种症状。
  • 咳嗽占36%(n=4707),66%的参与者报告呼吸困难。
  • 仅6%的参与者报告警示症状,包括咯血与体重下降。

关键数值与推荐

  • 警示症状定义为近1年咯血与3个月内非刻意体重下降≥5 kg。
  • 非特异症状定义为咳嗽(6周内起病)与呼吸困难(mMRC评分≥1)。
  • 研究对象为符合基线低剂量CT筛查条件的参与者,结局为1年内肺癌诊断。

临床怎么用

  • 提示筛查人群中症状普遍存在,问诊症状不应简单排除筛查对象。
  • 对有呼吸道或警示症状者应关注其1年内肺癌诊断风险可能升高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chest . 2026 Jun 30:S0012-3692(26)00918-9. doi: 10.1016/j.chest.2026.03.048. Online ahead of print. ABSTRACT BACKGROUND: Lung cancer screening is now widely adopted across health care systems. Screening typically occurs in asymptomatic individuals. Because symptoms of lung cancer overlap with those of chronic conditions, defining asymptomatic screening is challenging. This study outlines the frequency of symptomatic participants in a lung cancer screening trial. RESEARCH QUESTION: How common are respiratory and red flag symptoms in lung cancer screening participants, and how do these symptoms impact screening outcomes? STUDY DESIGN AND METHODS: The SUMMIT study was a prospective observational cohort study to assess the implementation of low-dose CT screening for lung cancer. Baseline clinical assessments collected self-reported symptoms, medical history, demographics, and spirometry. Hemoptysis (in last year) and unintentional weight loss (≥ 5 kg in 3 months) were classified as red flag symptoms, and cough (acute: onset 6 weeks) and dyspnea (modified Medical Research Council scale score ≥ 1) were classified as nonspecific symptoms. Lung cancer diagnoses within 1 year were ascertained. Multivariable logistic regression was used to assess associations between symptoms and lung cancer. RESULTS: Among 13,035 participants eligible for a baseline LDCT scan, 76% (n = 9,859) reported at least 1 symptom. Cough was present in 36% (n = 4,707), and 66% of participants reported dyspnea. Only 6% of participants reported red flag symptoms, including hemoptysis and weight loss. The presence of any of these symptoms was associated with higher likelihood of lung cancer diagnosis in the year after assessment (OR, 1.45; P = .03, adjusted for other baseline factors). INTERPRETATION: Our results show that symptoms are commonly reported in those undergoing lung cancer screening and those with symptoms are more likely to be diagnosed with lung cancer. PMID: 42379289 | DOI: 10.1016/j.chest.2026.03.048

来源:PubMed 顶刊 · 肺结节与肺癌筛查,查看原文。版权归原作者所有。

引用

  1. PubMed 顶刊 · 肺结节与肺癌筛查:Symptom Prevalence and Impact on Lung Cancer Risk in the SUMMIT Study

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。